Company Long-Term Loans and Borrowings: aTyr (ATYR)

Public company logo of aTyr Pharma Inc (ATYR)

aTyr Pharma, Inc. (ATYR) specializes in developing innovative immunological agents. This price chart visualizes the effectiveness of management, which strictly limits capital expenditures and transparently reports on the progress of efzofitimod trials, with the indicator standing at 0.01. The brand's competitiveness is driven by exclusive patents on tRNA synthetases. A staff of top-tier biologists is retained through flexible management and attractive research-based stock options.

ATYR aTyr Pharma, Inc. Company Long-Term Debts (06/06/2024 - 10/30/2026)

aTyr (ATYR) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price atyrpharma.com|ATYR - Price Target Chart
- company stock exchange capitalization indicators:
Market Value aTyr Pharma|ATYR - Total Company Value
- book capitalization information:
Accounting Value per Share aTyr Pharma|ATYR - Book Capitalization|Market Capitalization to Book Value Ratio atyrpharma.com|ATYR - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio aTyr Pharma, Inc.|ATYR - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient aTyr Pharmaceuticals|ATYR - Company Debts|Debt to Book Value aTyr Pharma|ATYR - Company Long-Term Debt|Company Current Liabilities aTyr Pharma|Quick Ratio atyrpharma.com
- earnings and multiples data:
ATYR - Company Net Income
Analysis of all company metrics:ATYR - atyrpharma.com
Brand item of aTyr Pharma, Inc.

The operational activities of aTyr Pharma, Inc. (ATYR) within the stable US legal framework correlate directly with the dynamics of the corporation's long-term loans and borrowings. This indicator aggregates obligations with a maturity of over one year, measuring the volume of capital raised to fund immune research, which allows for an assessment of the company's financial stability and asset quality under conditions of minimal geopolitical pressure.

Competitors of aTyr Pharma, Inc. (ATYR)

Company Long-Term Debts argenx.com ARGX|BNTX - Company Long-Term Debt|Company Long-Term Loans and Borrowings ABVX (abivax.com)|ADMA Bio (ADMA) - Company Long-Term Debt|Company Long-Term Liabilities Protagonist Corp|IMVT (Immunovant, Inc.) - Company Long-Term Debts|Company Long-Term Debts kiniksa.com|Company Long-Term Liabilities GRFS (Grifols)|ADPT (Adaptive Biotech) - Company Long-Term Loans and Borrowings|Company Long-Term Debts CLDX (Celldex)|Long-Term Debt Volume Aurinia Corp (AUPH)|BCRX - Company Long-Term Debt|veratx.com (VERA) - Company Long-Term Liabilities|Dianthus Therapeutics, Inc. (DNTH) - Company Long-Term Debt|Company Long-Term Liabilities Pharvaris NV|Company Long-Term Liabilities ABCL|Company Long-Term Debts Tourmaline|Company Long-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Long-Term Indebtedness|Company Long-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Long-Term Debt|Zenas Biopharma, Inc. - Company Long-Term Debts|IMNM - Company Long-Term Debts|GOSS (Gossamer Bio, Inc.) - Company Long-Term Liabilities|KALV: Amount of Long-Term Liabilities|Company Long-Term Liabilities SEPN|Long-Term Debt Pieris Pharma PVLA|Company Long-Term Debt Savara Corp (SVRA)|RIGL (Rigel Corp) - Company Long-Term Loans and Borrowings|AnaptysBio, Inc. - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings ATXS|ENGN - Company Long-Term Debt|Long-Term Liabilities RAPT|JBIO: Company Long-Term Debts|Aclaris Therapeutics, Inc - Company Long-Term Loans and Borrowings|KYTX (Kyverna Therapeutics) - Company Long-Term Debts|Company Long-Term Debts tizianalifesciences.com|Company Long-Term Debt Cabaletta Bio (CABA)|VTYX (Ventyx Biosciences Inc.) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Theratechnologies Inc THTX|AVTX - Company Long-Term Liabilities|Eledon Pharmaceuticals - Company Long-Term Debts|AGEN - Company Long-Term Debts|CLYM (Climb Bio) - Company Long-Term Liabilities|zurabio.com - Company Long-Term Loans and Borrowings|ADAG (Adagene Inc) - Company Long-Term Debts|Ikena Oncology, Inc. (IMA) - Long-Term Debt Volume|Company Long-Term Debt Shattuck Labs, Inc. (STTK)|equilliumbio.com - Company Long-Term Indebtedness|Company Long-Term Debts CNTB (Connect Biopharma Holdings Limited)|IMUX - Company Long-Term Liabilities|ATRA: Company Long-Term Liabilities|Long-Term Debt Volume InflaRx N.V. IFRX|XFOR: Company Long-Term Debts|Adicet Bio, Inc. (ACET) - Company Long-Term Debts|Company Long-Term Liabilities CELU|INMB (INmune Bio Inc) - Amount of Long-Term Liabilities|Company Long-Term Liabilities BRNS (Barinthus Bio)|KZR - Long-Term Debt|Company Long-Term Debt SAB Biotherapeutics SABS|Company Long-Term Loans and Borrowings AKTX|ENLV - Company Long-Term Debt|Long-Term Liabilities QTTB|GOVX: Company Long-Term Debts|Edesa Biotech Corp - Company Long-Term Loans and Borrowings|IBIO (iBio, Inc.) - Company Long-Term Debts|Company Long-Term Debts Carisma Tx|Company Long-Term Debt XTL Biopharmaceuticals Ltd. (XTLB)|BOLT (boltbio.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debt HCW Biologics HCWB|APVO - Company Long-Term Liabilities|AIM ImmunoTech - Company Long-Term Debts|ADTX - Company Long-Term Debts|GRI (GRI Bio) - Company Long-Term Liabilities|XORTX Therapeutics Inc - Company Long-Term Loans and Borrowings|HIND (ReShape Lifesciences) - Company Long-Term Debts|Revelation Biosciences Corp (REVB) - Long-Term Debt Volume|Company Long-Term Debt Indaptus Therapeutics (INDP)|Company Long-Term Liabilities scinai.com SCNI|Company Long-Term Debt CalciMedica CALI|AFMD - Company Long-Term Liabilities|ALLK: Company Long-Term Liabilities|HOOK - Company Long-Term Debts|igmbio.com (IGMS) - Company Long-Term Debt|Company Long-Term Indebtedness ITOS|OCEA (Ocean Biomedical) - Company Long-Term Debts|Long-Term Debt TC BioPharm (Holdings) Plc TCBP|Company Long-Term Debts THRD